Combination Products: FDA Issues Draft of cGMPs

Overview:

In its recently released “Pharmaceutical cGMPs for the 21st Century—a Risk-Based Approach,” FDA provided some initial guidance on good manufacturing practice for combination products (such as drug and device pairings). This is a draft document, meant to elicit comments and concerns